Carcinoids (DBCOND0040632)
Identifiers
- Synonyms
- Carcinoid / Benign carcinoid tumor of unspecified site / Carcinoid tumour / Carcinoid tumour NOS / Carcinoid Tumor / Carcinoid tumor - morphology (morphologic abnormality) / Carcinoid tumours / Carcinoid tumor (disorder)
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05361668 Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome treatment 2 active_not_recruiting NCT01327612 Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) treatment 2 completed NCT02038738 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors diagnostic 1 / 2 unknown_status NCT03623984 Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers treatment 0 withdrawn NCT03583528 DOTATOC PET/CT for Imaging NET Patients No drug interventions Not Available Not Available recruiting NCT00050349 EPO906 in Carcinoid and Other Neuroendocrine Tumors treatment 2 completed NCT01165658 Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies No drug interventions treatment 1 terminated NCT00646022 Natural History of Familial Carcinoid Tumor No drug interventions Not Available Not Available recruiting NCT00314925 Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features treatment 1 unknown_status NCT00339131 ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid diagnostic 1 completed NCT05477576 Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy treatment 3 recruiting NCT02270567 RegisterNET - A Registry for Neuroendocrine Tumors in the USA No drug interventions Not Available Not Available enrolling_by_invitation NCT01322542 YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome treatment 2 recruiting NCT00688623 RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe treatment 2 completed